Sandoz Group 

$81.87
319
-$3.71-4.34% Today

Statistics

Day High
83.89
Day Low
81.67
52W High
93.31
52W Low
39.72
Volume
35,359
Avg. Volume
-
Mkt Cap
0
P/E Ratio
41.04
Dividend Yield
1.25%
Dividend
1.03

Upcoming

Dividends

1.25%Dividend Yield
Jun 25
$0.73
Jun 24
$0.5
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
41.04%

Earnings

25FebExpected
Q2 2024
Q4 2024
Q2 2025
Q4 2025
1
1.34
1.68
2.03
Expected EPS
1.826667
Actual EPS
2.025

Financials

0%Profit Margin
Unprofitable
2023
2024
20.71BRevenue
0Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SDZNY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap38.65B
Teva Pharmaceutical Industries is a leading global pharmaceutical company that produces generic and specialty medicines, directly competing with Sandoz in the generics market.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie operates in the pharmaceuticals sector focusing on branded drug development, competing with Sandoz's biosimilars and generic pharmaceuticals.
Pfizer
PFE
Mkt Cap156.77B
Pfizer is a research-based biopharmaceutical company that competes with Sandoz in the development and marketing of generic and biosimilar drugs.
Novartis
NVS
Mkt Cap293.34B
Novartis, the parent company of Sandoz, competes in the pharmaceutical industry but is listed separately due to its broader portfolio of patented drugs, which indirectly competes with Sandoz's generics and biosimilars.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson is a comprehensive healthcare company that produces a wide range of pharmaceutical products, competing with Sandoz in various therapeutic areas.
Merck
MRK
Mkt Cap294.39B
Merck & Co. is a global healthcare company that produces prescription medicines, vaccines, biologic therapies, and animal health products, competing with Sandoz in the pharmaceutical sector.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline is a global healthcare company that researches and develops a wide range of pharmaceutical products, competing with Sandoz in the generics and biosimilars market.
Sanofi
SNY
Mkt Cap115.14B
Sanofi is a global biopharmaceutical company focused on human health, competing with Sandoz in the areas of generic drugs and biosimilars.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Sandoz in developing and marketing biosimilar products and in the generics field.

About

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.
Show more...
CEO
Mr. Richard Saynor
Employees
22049
Country
United States
ISIN
US7999261008

Listings

0 Comments

Share your thoughts

FAQ

What is Sandoz Group stock price today?
The current price of SDZNY is $81.87 USD — it has decreased by -4.34% in the past 24 hours. Watch Sandoz Group stock price performance more closely on the chart.
What is Sandoz Group stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sandoz Group stocks are traded under the ticker SDZNY.
Is Sandoz Group stock price growing?
SDZNY stock has fallen by -5.16% compared to the previous week, the month change is a +6.91% rise, over the last year Sandoz Group has showed a +103.53% increase.
When is the next Sandoz Group earnings date?
Sandoz Group is going to release the next earnings report on August 05, 2026.
What were Sandoz Group earnings last quarter?
SDZNY earnings for the last quarter are 2.03 USD per share, whereas the estimation was 1.83 USD resulting in a +10.86% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sandoz Group revenue for the last year?
Sandoz Group revenue for the last year amounts to 20.71B USD.
What is Sandoz Group net income for the last year?
SDZNY net income for the last year is 0 USD.
Does Sandoz Group pay dividends?
Yes, SDZNY dividends are paid annual. The last dividend per share was 0.73 USD. As of today, Dividend Yield (FWD)% is 1.25%.
How many employees does Sandoz Group have?
As of April 21, 2026, the company has 22,049 employees.
In which sector is Sandoz Group located?
Sandoz Group operates in the Health & Wellness sector.
When did Sandoz Group complete a stock split?
Sandoz Group has not had any recent stock splits.
Where is Sandoz Group headquartered?
Sandoz Group is headquartered in Basel, United States.